Evaluation of endocrine therapy of prostate cancer by assessing tumor markers and hormone parameters. Hormonal "cross-over" treatment of false endocrine independent tumors
Kraljić, I.; Tarle, M.
Progress in Clinical and Biological Research 243b: 521-525
1987
ISSN/ISBN: 0361-7742 PMID: 3659050 Document Number: 293256
Document emailed within 1 workday
Related Documents
Kawaguchi, T.; Mayama, I.; Iwabuchi, I.; Ogasawara, M.; Tsukui, A. 2010: Chemo-endocrine therapy with low-dose cisplatin, UFT, and dexamethasone for hormone-refractory prostate cancer patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(10): 1921-1925Lauritzen, C. 1979: Hormonal regulation and hormone therapy in childhood and adolescence. Part 1: development of endocrine glands, hormone production, menarche and secondary sex characteristics Fortschritte der Medizin 97(18): 863-868
Kelly, W.K. 1998: Endocrine withdrawal syndrome and its relevance to the management of hormone refractory prostate cancer European Urology 34(Suppl): 18-23
Horiguchi, A.; Hatakeyama, N.; Ikeuchi, K. 1999: Dynamics of prostate-specific antigen as prognostic factors in endocrine treatment for prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 45(1): 31-35
Usami, M. 1998: Endocrine therapy for prostate cancer in the future Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(6): 817-822
Mayer, F.J.; Crawford, E.D. 1994: The role of endocrine therapy in the management of local and distant recurrence of prostate cancer following radical prostatectomy or radiation therapy Urologic Clinics of North America 21(4): 707-715
Kamoto, T. 2002: Management of side effects of endocrine treatment for prostate cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 11): 299-303
Tachibana, K.; Ohtake, T.; Saji, S. 2016: III. Novel Endocrine Therapy with Signal Transduction Inhibitors for Hormone Dependent Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(13): 2509-2512
Labrie, F.; Dupont, A.; Giguère, M.; Borsanyi, J.P.; Lacourciere, Y.; Bélanger, A.; Lachance, R.; Emond, J.; Monfette, G. 1988: Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancer Progress in Clinical and Biological Research 260: 41-62
Iglódi, F. 1989: Endocrine therapy monitored by hormone cytological examination in advanced female breast cancer Therapia Hungarica 37(4): 205-208
Boccardo, F.; Pace, M. 1993: Endocrine treatment of prostate cancer: standard treatment and new perspectives In Vivo 7(5): 423-424
Okamoto, T. 2001: Tumor markers for endocrine neoplasms Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(4): 561-565
Hessman, O.; Lindberg, D.; Skogseid, B.; Carling, T.; Hellman, P.; Rastad, J.; Akerström, G.; Westin, G. 1998: Mutation of the multiple endocrine neoplasia type 1 gene in nonfamilial, malignant tumors of the endocrine pancreas Cancer Research 58(3): 377-379
Hrnciar, J.; Hrnciarová, M.; Zúbek, V.; Hornová, V.; Korbacková, R. 1987: Proteohormones as markers of malignant tumors. Paraneoplastic endocrine syndromes Vnitrni Lekarstvi 33(10): 910-918
Kumamoto, Y.; Tsukamoto, T.; Umehara, T.; Shimazaki, J.; Fuse, H.; Ohshima, H.; Takeuchi, H.; Yoshida, O.; Okada, K.; Saito, Y. 1991: Clinical studies on endocrine therapy for prostatic carcinoma (4): Initial response to endocrine therapy and prognosis Hinyokika Kiyo. Acta Urologica Japonica 37(11): 1505-1510
Nomura, Y.; Tashiro, H.; Hisamatsu, K.; Toi, M. 1988: Effects of high-dose medroxyprogesterone acetate in advanced breast cancer, with special reference to prior endocrine therapy and hormone receptors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(3): 513-518
Wilding, G. 1995: Endocrine control of prostate cancer Cancer Surveys 23: 43-62
Falcone, T.; Falutz, G.; Tolis, G. 1982: LH-RH-endocrine manipulation in cancer of the prostate Biomedicine and PharmacoTherapy 36(8-9): 344-348
Geyer, G. 1980: New results in the field of endocrinology with relevance for medical practice. Hyperprolactemia, endocrine adenomatoses, paraneoplastic hormone secretion and hormone therapy of breast carcinoma Wiener Medizinische Wochenschrift 130(15-16): 501-509
Kitamura, K.; Shirato, H.; Shimizu, S.; Miyasaka, K.; Demura, T.; Shinohara, N.; Harabayashi, T. 2000: Real-time tumor-tracking radiotherapy combined with neoadjuvant hormonal therapy for prostate cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 58 Suppl: 326-329